Clinical Trial

Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure

Study acronym: KETO-AHF
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized, double-blind, placebo-controlled trial to investigate the clinical efficacy of treatment with exogenous dietary ketone supplement containing 1,3-butanediol in patients hospitalized with acute heart failure (AHF), potentially leading to better clinical outcomes.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-21; most recent amendment 2025-06-04.
Status change: Not Yet Recruiting → Recruiting 2025-03-19
Trial Details
NCT Number NCT06653725
Lead Sponsor Aarhus University Hospital
Collaborators: Viborg Regional Hospital, Hospitalsenhed Vest, Herning, Odense University Hospital, Aalborg University Hospital, Rigshospitalet, Denmark, Copenhagen University Hospital at Herlev, Amager Hospital
Conditions Acute Heart Failure (AHF)
Enrollment 250 participants
Start Date 2025-03-20
Primary Completion 2027-11-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-05